ポスト
Griffith University developed a single-dose intranasal live-attenuated vaccine, CDO-7N-1, that provides broad protection against SARS-CoV-2 and its variants. https://t.co/5Bxo8jvfts
メニューを開くGriffith University developed a single-dose intranasal live-attenuated vaccine, CDO-7N-1, that provides broad protection against SARS-CoV-2 and its variants. https://t.co/5Bxo8jvfts
メニューを開く